The antihypertensive effect of verapamil in patients with chronic renal failure.
The calcium antagonist verapamil has been demonstrated to be effective in reducing hypertension in patients in whom sodium intake was not restricted. The present study evaluated the effect of verapamil in reducing hypertension in patients with chronic renal failure on low or high sodium diets. Also, the present study evaluated the effect of verapamil on proteinuria in chronic renal failure patients who were administered a normal and low protein diet. The results reveal that verapamil-SR 240 mg daily is effective in reducing hypertension in patients with chronic renal failure and the effect of verapamil is equal in patients on a high or low sodium intake. In addition, verapamil-SR 240 mg daily is effective in maintaining reduced proteinuria in chronic renal failure patients on low protein diet and may prevent proteinuria in such patients on a normal protein diet. Therefore, verapamil-SR 240 mg daily appears to be an excellent choice for the treatment of hypertensive chronic renal failure patients.
Rodicio
J L
JL
University of Madrid, Hospital 12 de Octubre, Spain.
Alcazar
J M
JM
Ruilope
L M
LM
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004039:Diet, Sodium-Restricted; D004044:Dietary Proteins / Q000008:administration & dosage; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000150:complications*; D011507:Proteinuria / Q000209:etiology / Q000517:prevention & control; D012079:Renal Circulation / Q000187:drug effects; D014700:Verapamil / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D004044:Dietary Proteins; D014700:Verapamil